Cargando…
Withaferin A: From Ancient Remedy to Potential Drug Candidate
Withaferin A (WA) is a pivotal withanolide that has conquered a conspicuous place in research, owning to its multidimensional biological properties. It is an abundant constituent in Withania somnifera Dunal. (Ashwagandha, WS) that is one of the prehistoric pivotal remedies in Ayurveda. This article...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705790/ https://www.ncbi.nlm.nih.gov/pubmed/34946778 http://dx.doi.org/10.3390/molecules26247696 |
_version_ | 1784622033834868736 |
---|---|
author | Sultana, Tahira Okla, Mohammad K. Ahmed, Madiha Akhtar, Nosheen Al-Hashimi, Abdulrahman Abdelgawad, Hamada Haq, Ihsan-ul- |
author_facet | Sultana, Tahira Okla, Mohammad K. Ahmed, Madiha Akhtar, Nosheen Al-Hashimi, Abdulrahman Abdelgawad, Hamada Haq, Ihsan-ul- |
author_sort | Sultana, Tahira |
collection | PubMed |
description | Withaferin A (WA) is a pivotal withanolide that has conquered a conspicuous place in research, owning to its multidimensional biological properties. It is an abundant constituent in Withania somnifera Dunal. (Ashwagandha, WS) that is one of the prehistoric pivotal remedies in Ayurveda. This article reviews the literature about the pharmacological profile of WA with special emphasis on its anticancer aspect. We reviewed research publications concerning WA through four databases and provided a descriptive analysis of literature without statistical or qualitative analysis. WA has been found as an effective remedy with multifaceted mechanisms and a broad spectrum of pharmacological profiles. It has anticancer, anti-inflammatory, antiherpetic, antifibrotic, antiplatelet, profibrinolytic, immunosuppressive, antipigmentation, antileishmanial, and healing potentials. Evidence for wide pharmacological actions of WA has been established by both in vivo and in vitro studies. Further, the scientific literature accentuates the role of WA harboring a variable therapeutic spectrum for integrative cancer chemoprevention and cure. WA is a modern drug from traditional medicine that is necessary to be advanced to clinical trials for advocating its utility as a commercial drug. |
format | Online Article Text |
id | pubmed-8705790 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87057902021-12-25 Withaferin A: From Ancient Remedy to Potential Drug Candidate Sultana, Tahira Okla, Mohammad K. Ahmed, Madiha Akhtar, Nosheen Al-Hashimi, Abdulrahman Abdelgawad, Hamada Haq, Ihsan-ul- Molecules Review Withaferin A (WA) is a pivotal withanolide that has conquered a conspicuous place in research, owning to its multidimensional biological properties. It is an abundant constituent in Withania somnifera Dunal. (Ashwagandha, WS) that is one of the prehistoric pivotal remedies in Ayurveda. This article reviews the literature about the pharmacological profile of WA with special emphasis on its anticancer aspect. We reviewed research publications concerning WA through four databases and provided a descriptive analysis of literature without statistical or qualitative analysis. WA has been found as an effective remedy with multifaceted mechanisms and a broad spectrum of pharmacological profiles. It has anticancer, anti-inflammatory, antiherpetic, antifibrotic, antiplatelet, profibrinolytic, immunosuppressive, antipigmentation, antileishmanial, and healing potentials. Evidence for wide pharmacological actions of WA has been established by both in vivo and in vitro studies. Further, the scientific literature accentuates the role of WA harboring a variable therapeutic spectrum for integrative cancer chemoprevention and cure. WA is a modern drug from traditional medicine that is necessary to be advanced to clinical trials for advocating its utility as a commercial drug. MDPI 2021-12-20 /pmc/articles/PMC8705790/ /pubmed/34946778 http://dx.doi.org/10.3390/molecules26247696 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Sultana, Tahira Okla, Mohammad K. Ahmed, Madiha Akhtar, Nosheen Al-Hashimi, Abdulrahman Abdelgawad, Hamada Haq, Ihsan-ul- Withaferin A: From Ancient Remedy to Potential Drug Candidate |
title | Withaferin A: From Ancient Remedy to Potential Drug Candidate |
title_full | Withaferin A: From Ancient Remedy to Potential Drug Candidate |
title_fullStr | Withaferin A: From Ancient Remedy to Potential Drug Candidate |
title_full_unstemmed | Withaferin A: From Ancient Remedy to Potential Drug Candidate |
title_short | Withaferin A: From Ancient Remedy to Potential Drug Candidate |
title_sort | withaferin a: from ancient remedy to potential drug candidate |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705790/ https://www.ncbi.nlm.nih.gov/pubmed/34946778 http://dx.doi.org/10.3390/molecules26247696 |
work_keys_str_mv | AT sultanatahira withaferinafromancientremedytopotentialdrugcandidate AT oklamohammadk withaferinafromancientremedytopotentialdrugcandidate AT ahmedmadiha withaferinafromancientremedytopotentialdrugcandidate AT akhtarnosheen withaferinafromancientremedytopotentialdrugcandidate AT alhashimiabdulrahman withaferinafromancientremedytopotentialdrugcandidate AT abdelgawadhamada withaferinafromancientremedytopotentialdrugcandidate AT haqihsanul withaferinafromancientremedytopotentialdrugcandidate |